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Abstract
The 16S-23S rRNA gene intergenic spacer (ITS) was analysed by RFLP in this study to identify A. baumannii from 139 
isolates from four hospitals (identified as A, B, C and D). One hundred and twenty of these isolates (86.3%) belonged to 
the A. baumannii species; those identified as being A. baumannii were found to be polyclonal (19 clone groups) when 
determining the genetic relationships, 16 of them being found in hospital C. Hospitals A, B and D shared two clone 
groups isolated during different years. This study describes a rapid and easy method for genospecies identification of 
Acinetobacter baumannii.
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Resumen
Con el objeto de identificar  la genomoespecie Acinetobacter baumannii, se estudiaron 189  aislamientos pertenecientes 
al Complejo Acinetobacter baumannii-Acinetobacter calcoaceticus provenientes de cuatro hospitales colombianos (deno-
minados A, B ,C, D) mediante el análisis por RFLP-PCR de la región intergénica espaciadora (ITS) de los genes 16S y 23S 
rRNA. Se encontraron 120 aislamientos (86.3 % ) pertenecientes a la especie A. baumannii. La estructura de la población 
fue policlonal, con 19 grupos clonales, 16 de los cuales se hallaron en el hospital C . En los hospitales A, B, y D se encontra-
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ron 2 grupos clonales aislados durante diferentes años. En este estudio se propone un método método rápido y fácil para 
la identificación de Acinetobacter baumanii.
Palabras clave: Complejo Acinetobacter baumannii- Acinetobacter calcoaceticus; Región intergénica espaciadora (ITS); 
RFLP - PCR.
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attempt has been made to discriminate between these 
species (28, 30, 36); this study has thus been aimed at 
discriminating Acinetobacter baumannii by restricting 
intergenic spacer region PCR products.
Materials and Methods
Bacterial strains. A total of 139 isolates were obtai-
ned from four Colombian hospitals during 2004, 2005, 
2007 and 2009 (the hospitals were designated A-D). 
They were stored at -70 °C in the Molecular Epide-
miology Laboratory’s strainbank at the Instituto de 
Biotecnología, Universidad Nacional de Colombia; 
eighty-eight of the isolates (63.3%) were related to 
infection, a further 46 (33.1%) to colonisation and 5 
(3.6%) were recovered from the clinical environment. 
The strains related to infection and colonisation were 
recovered from blood cultures (58/139), secretions 
(23/139), catheters (23/139) and urine (30/139). They 
had previously been identified as being A. baumannii-A. 
calcoaceticus complex by Vitek (Biomerieux, France) 
and all isolates (except one) were classified as being 
multi-resistant or resistant (8). Cefotaxime, ceftazidime, 
cefepime, imipenem, meropenem, ampicillin-sulbac-
tam, piperacillin-tazobactam, ciprofloxacin, amikacin, 
gentamicin and trimethoprim-sulphametoxazole were 
the antibiotics evaluated in this study. Multi-resistant 
strains were considered as being those having exhibi-
ted resistance to at least three classes of antimicrobial 
agent. A. baumannii ATCC 19606 was used as RFLP-
PCR control.
Amplifying the intergenic spacer region. DNA was ob-
tained by cell lysis in distilled water from colonies grown 
for 18h at 37 °C (33). The ITS was amplified in an iCycler 
thermocycler (BioRad, USA), using 1512F (5’GTCGTAA-
CAAGGTAGCCGTA3’) and 6R (5’GGGTTYCCCCRTT-
CRGAAAT3’) primers at 62 °C annealing temperature, 
as previously reported by Chang et al. (4). The products 
were visualised in 1% agarose gel electrophoresis and 
their sizes were estimated by comparison with a 100 
bp DNA ladder (Invitrogen, San Diego, CA).
Introduction
Different Acinetobacter species have been well cha-
racterised as being a major public health concern as 
they have been responsible for well-characterised epi-
demic outbreaks all around the world (1, 4, 31). Hy-
bridisation studies have shown that the Acinetobacter 
genus is biochemically and genetically heterogeneous. 
Thirty-three genomic species (genospecies) have been 
shown to belong to this genus to date (3, 4, 31). Due to 
the close phenotypic and genetic relationship between 
genospecies 1 (A. calcoaceticus), 2 (A. baumannii), 3 
and 13TU and the difficulties hampering dividing them 
by classical biochemical reactions, genospecies1, 2, 3 
and 4 have been reported as being A. baumannii-A. 
calcoaceticus complex or as A. baumannii as the bio-
chemical differences between these four species are 
subtle and no commercial automated identification 
systems are capable of discriminating within the A. 
baumannii-A. calcoaceticus complex. However, A. 
baumannii remains mainly responsible for outbreaks 
sensu stricto (1, 4, 13, 31).
Epidemiological studies have demonstrated the useful-
ness of being able to distinguish the species from the 
complex (35); accurately identifying species within the 
A. baumannii-A. calcoaceticus complex is therefore im-
portant for elucidating these species’ ecology, epide-
miology and pathology (4, 16, 17, 31). Several genetic 
methods have been developed for genomic species 
identification within the A. baumannii-A. calcoaceticus 
complex; these methods include amplified rDNA, res-
triction analysis (ARDRA), ribosomal operon analysis, 
recA gene and /or rpoB gene sequencing and 16S-23S 
rRNA gene intergenic spacer analysis (4, 6, 11, 19, 25, 
27). The latter approach has shown that the interge-
nic spacer (ITS) region sequence between the 16S and 
23S rRNA genes has low intraspecies variation and 
high levels of interspecies divergence (5). This region 
could thus lead to identifying species within the same 
genus due to variability in both length and sequence 
(10, 18, 26, 32).
Although several epidemiological reports have analy-
sed outbreaks produced by these microorganisms, no 
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Restriction fragment length polymorphism (RFLP) 
PCR. The methodology established by Dolzani et al., 
was used for identifying A. baumannii according to ITS 
sequence (6). Briefly, in silico analysis led to selecting 
the Mbo I enzyme to distinguish restriction patterns for 
A. baumannii. The sequences used in the evaluation 
were those reported by Chang et al., which are availa-
ble from GenBank (AY601820-AY601848) (4). Once 
the enzyme had been selected, amplicons from the 
isolates’ ITS were restricted, fragment patterns were 
analysed by 3.5% agarose gel electrophoresis (NuSie-
ve FMC Bioproducts) and a photographic record was 
made (Gel-Doc BioRad). The ITS from 26 isolates were 
sequenced with ABI Prism 3730xI-PE (Applied Biosys-
tems, Macrogen Inc.).
Molecular typing. The genetic structure of populations 
from hospitals A to D had been obtained in previous 
studies by repetitive extragenic palindromic PCR (REP-
PCR); polyclonal populations and some clone groups 
were found (28, 29, 30). The genetic relationships 
amongst isolates identified as being A. baumannii were 
evaluated by REP-PCR typing, using REP IRI (5’IIICGIC-
GICATCIGGC3’) and REP 2I (5’ICGICTTATCIGGCC-
TAC3’) primers and 46 °C annealing temperature (34). 
PCR products were resolved by 2% agarose gel elec-
trophoresis (4.6 V / cm) in 0.5 X TBE buffer for 2 hours 
and visualised with 1μg/mL ethidium bromide staining; 
the gels were photographed (Gel-Doc BioRad). The 
percentage of isolates’ electrophoretic profile simila-
rity was estimated by using the Dice coefficient; clus-
ter analysis was performed by using the unweighted 
pair-group method with arithmetic mean (UPGMA) 
algorithm and GelCompar II software (version 6.0) 
(Applied Maths, Sint-Martens-Latem, Belgium). Isolates 
having ≥75% similarity were considered to be clone 
groups.
Results
Genospecies identification. The ITS region of 139 clini-
cal isolates and the A. baumannii ATCC 19606 referen-
ce strain were amplified with 1512F and 6R primers (4). 
A 786 bp amplification product was obtained for each 
isolate studied here. All ITS obtained were analysed by 
restriction fragment length polymorphism (RFLP) to 
discriminate the Acinetobacter baumannii specie using 
the MboI enzyme which, according to in silico results, 
led to differentiating such specie from the others in 
the complex. As expected from in silico modelling and 
relative isolation frequency, 122 isolates displayed the 
345, 327 49, 36 and 29 bp fragments corresponding 
to A. baumannii. The ITS from 26 isolates sequenced 
had 100% similarity with those deposited in Genbank 
for the A. baumannii specie. Genotyping. The dendro-
gram obtained with the 120 strains identified as being 
A. baumannii revealed 19 clonal groups, having 75% 
similarity (data not shown).
Discussion
The genus Acinetobacter consists of 33 named and 
unnamed species. A. baumannii, A. calcoaceticus, Aci-
netobacter 13TU and Acinetobacter genomospecies 3 
are phenotypically and genotypically similar, being fre-
quently grouped as the A baumannii-A. calcoaceticus 
complex (ABC); three of this complex’s members are 
frequently found in clinical samples. A. calcoaceticus is 
a soil microorganism which is rarely found in clinical 
samples. The complex has become important during 
the last few years due to the increase of outbreaks in 
hospitals and the fact that the strains involved are re-
sistant to several antibiotics. Grouping the 4 species in 
the complex is inconvenient as this blurs the variations 
in each species’ biology and epidemiology. Identifying 
the complex’s species is thus important for ascertai-
ning each one’s ecology, epidemiology and pathology 
(4, 16, 17, 31, 35).
Variations being observed in antimicrobial susceptibili-
ty, clinical manifestations and the outcome for patients 
suffering from invasive infections caused by different 
species from the complex have demonstrated the clini-
cal importance of differentiating the complex’s species 
(35).
Dolzani proposed a method based on RFLP of the ITS 
in 1995 for identifying species from the complex using 
ALU1 and Nde 2 enzymes. However, Dolzani conside-
red at the time that, in spite of its simplicity, it still could 
not be used in routine trials in clinical laboratories (6). 
This study has described a rapid and easy identifica-
tion method based on restricting intergenic spacer 
region PCR products with which Ab can be differenti-
ated from the other members of the complex, using 
just one restriction enzyme for digesting the ITS region 
and thereby providing an alternative for identifying A. 
baumannii species from genomic species within the 
A. baumannii-A. calcoaceticus complex which are dif-
ficult to identify by phenotypic identification systems 
(4). Given that many clinical laboratories now have the 
necessary equipment for using it, this method could 
be considered as an alternative for identifying Acineto-
bacter baumannii in such institutions.
One hundred and twenty of the 139 isolates previous-
ly identified as being A. baumannii by Vitek belonged 
to that species, suggesting that A. baumannii is the ge-
nospecies being most frequently isolated in hospitals 
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(7, 20, 15, 22). Eighteen of the 19 isolates which were 
not identified as being A. baumannii by the method 
being used were identified as being A13 TU and the 
other one as Acinetobacter genomospecies 3 by ITS 
sequencing.
Great variability was found amongst isolates identified 
as A. baumannii. Two A. baumannii clonal groups were 
found to be distributed throughout hospitals A, B and 
D in Bogotá. Such distribution amongst the three hos-
pitals in Bogotá could be explained by patient transfer 
between hospitals.
Hospital C had the greatest percentage of clonal 
groups; such A. baumannii variability within a single 
hospital could be explained by epidemic and sporadic 
clones’ coexistence (9, 23).
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